Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024

OTC検査の世界市場予測(~2024年)

◆タイトル:Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024
◆商品コード:MD-7014
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年4月10日
◆ページ数:97
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥604,550見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥711,550見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥872,050見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

OTC検査の世界市場は、2018年の119億米ドルから2024年には222億米ドルに達し、この期間中11.0%の年平均成長率で成長すると予測されています。糖尿病は世界中で蔓延している疾患であり、OTC検査の需要に大きく貢献しています。 感染症も迅速かつ効果的な検査が必要です。 これら用途の検査の必要性は、OTC検査の開発と提供に対する政府の支援を増大させています。一方で、血糖値のセルフモニタリング/従来の血糖値モニタリングシステムやコレステロールモニタリングの侵襲的な計測法は、市場の成長に影響を与える可能性があります。当調査レポートでは、OTC検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別(血糖モニタリング検査、コレステロールモニタリング検査、感染症検査、便潜血検査、尿検査、薬物乱用検査)分析、技術別(イムノアッセイ、ラテラルフローアッセイ)分析、OTC検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Increasing prevalence of infectious diseases is expected to drive the overall growth of the OTC Test market.”The OTC Test market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during forecast period. Diabetes is a prominent affliction across the globe and a key contributor to the demand for OTC tests. Infectious diseases also require rapid and effective testing. The need for tests for both applications has resulted in growing government support for the development and provision of OTC tests. However, the invasive nature of self-monitoring/traditional blood glucose systems and cholesterol monitoring is likely to affect market growth to a certain extent.

“The infectious disease tests segment is expected to grow at the highest CAGR during the forecast period.”
The OTC Test market, by product, has been categorized into eight major segments— glucose monitoring tests, cholesterol tests, pregnancy & fertility tests, drugs-of-abuse tests, coagulation monitoring tests, urinalysis tests, infectious disease tests, and other tests. The infectious disease tests segment is estimated to grow at the highest CAGR during the forecast period. This market is majorly driven by factors such as the increasing number of HIV-infected individuals across the globe, coupled with increasing availability and awareness about HIV OTC testing in emerging markets such as India, Brazil, and China
“Asia Pacific projected to grow at the highest CAGR during the forecast period.”
In the OTC Test market, Asia Pacific is projected to record the highest growth during the forecast period. China, Japan, and India are the major markets for OTC Test in the Asia Pacific. Increasing prevalence of target conditions and infectious diseases and growing patient population base in emerging countries like India and China are expected to drive the growth of these markets during the forecast period.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the OTC Test market.
By Company Type: Tier 1–18%, Tier 2–39%, and Tier 3–43%
By Designation: C-level Executives–25%, Directors–20%, and Others–55%
By Region: North America–40%, Europe–27%, APAC–20%, and RoW–13%

The OTC Test market comprises major providers such as OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US). The study includes an in-depth competitive analysis of these key players in the OTC Test market, along with their company profiles, recent developments, and key market strategies.
Research Coverage:
The market study covers the OTC Test market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of product, analyte type, product, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall OTC Test market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 13
1.3.2 YEARS COVERED FOR THE STUDY 13
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 PRIMARY DATA 16
2.1.1 KEY DATA FROM PRIMARY SOURCES 16
2.2 SECONDARY DATA 17
2.2.1 KEY DATA FROM SECONDARY SOURCES 17
2.3 MARKET SIZE ESTIMATION 18
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4.1 ASSUMPTIONS FOR THE STUDY 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 OTC TESTS: MARKET OVERVIEW 25
4.2 OTC TESTS MARKET, BY TECHNOLOGY (2018–2024) 26
4.3 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT (2018) 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 29
5.2.1.1 Growing prevalence of diabetes 29
5.2.1.2 High prevalence of infectious diseases in developing countries 30
5.2.1.3 Growing support and collaboration for developing OTC tests 30
5.2.2 OPPORTUNITIES 31
5.2.2.1 Introduction of combined kits for testing pregnancy and ovulation 31
5.2.3 CHALLENGES 31
5.2.3.1 Invasiveness of blood glucose monitors and cholesterol monitors 31

6 OVER THE COUNTER TESTS MARKET, BY TECHNOLOGY 32
6.1 INTRODUCTION 33
6.2 LATERAL FLOW ASSAYS 33
6.2.1 LATERAL FLOW ASSAYS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 33
6.3 IMMUNOASSAYS 34
6.3.1 INCREASING USE OF IMMUNOASSAYS FOR PREGNANCY & INFECTIOUS DISEASE TESTING IS DRIVING MARKET GROWTH 34
6.4 DIPSTICKS 36
6.4.1 DIPSTICKS PROVIDE ONLY A QUALITATIVE ANALYSIS, WHICH IS A MAJOR FACTOR RESTRAINING MARKET GROWTH 36
7 OVER THE COUNTER TESTS MARKET, BY PRODUCT 38
7.1 INTRODUCTION 39
7.2 GLUCOSE MONITORING TESTS 39
7.2.1 GLUCOSE MONITORING TESTS DOMINATED THE OTC TESTS MARKET IN 2018 39
7.3 PREGNANCY & FERTILITY TESTS 41
7.3.1 ADVANTAGES OF PREGNANCY & FERTILITY TESTS HAVE DRIVEN COMPANIES TO FOCUS ON PRODUCT DEVELOPMENT 41
7.4 INFECTIOUS DISEASE TESTS 42
7.4.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES IS DRIVING MARKET GROWTH 42
7.5 COAGULATION MONITORING TESTS 44
7.5.1 COAGULATION MONITORING TESTS PROVIDE QUICK AND RELIABLE RESULTS 44
7.6 URINALYSIS TESTS 45
7.6.1 INCREASING PREVALENCE OF URINARY TRACT INFECTIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH 45
7.7 CHOLESTEROL TESTS 46
7.7.1 CONVENIENCE OF HOME-USE TESTS HAS EXPANDED THEIR USE 46
7.8 DRUGS-OF-ABUSE TESTS 48
7.8.1 RISING PRODUCTION AND CONSUMPTION OF ILLEGAL DRUGS HAVE DRIVEN THE FOCUS ON TESTING 48
7.9 OTHER TESTS 49
8 OVER THE COUNTER TESTS MARKET, BY REGION 51
8.1 INTRODUCTION 52
8.2 NORTH AMERICA 53
8.2.1 US 55
8.2.1.1 US to dominate the North America OTC tests market 55
8.2.2 CANADA 56
8.2.2.1 Increasing government initiatives to support the adoption of POC products to drive market growth in Canada 56

8.3 EUROPE 58
8.3.1 GERMANY 59
8.3.1.1 Germany is the fastest-growing market in Europe 59
8.3.2 FRANCE 61
8.3.2.1 High demand for glucose testing kits to drive market growth in France 61
8.3.3 UK 62
8.3.3.1 Increasing awareness of OCT tests among the users 62
8.3.4 REST OF EUROPE 63
8.4 ASIA PACIFIC 64
8.4.1 ASIA PACIFIC IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL OTC TESTS MARKET 64
8.5 REST OF THE WORLD 67
9 COMPETITIVE LANDSCAPE 69
9.1 OVERVIEW 69
9.2 VENDOR BENCHMARKING 69
9.3 COMPETITIVE LEADERSHIP MAPPING 69
9.3.1 VISIONARY LEADERS 69
9.3.2 INNOVATORS 69
9.3.3 DYNAMIC DIFFERENTIATORS 69
9.3.4 EMERGING COMPANIES 69
9.4 MARKET RANKING ANALYSIS, 2017 71
9.5 COMPETITIVE SITUATION AND TRENDS 72
9.5.1 PRODUCT LAUNCHES 72
9.5.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 72
9.5.3 ACQUISITIONS 73

10 COMPANY PROFILES 74
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 ROCHE DIAGNOSTICS 74
10.2 ABBOTT LABORATORIES 76
10.3 ORASURE TECHNOLOGIES 78
10.4 ACCUBIOTECH 80
10.5 LIA DIAGNOSTICS 81
10.6 LABSTYLE INNOVATIONS 82
10.7 SD BIOSENSOR 84
10.8 ACON LABORATORIES INC 85
10.9 SINOCARE 86
10.10 NOWDIAGNOSTICS COMPANY 88
10.11 I HEALTH LAB 89
10.12 BIOLYTICAL LABORATORIES 90
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX 91
11.1 DISCUSSION GUIDE 91
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 93
11.3 AVAILABLE CUSTOMIZATIONS 95
11.4 RELATED REPORTS 95
11.5 AUTHOR DETAILS 96

LIST OF TABLES

TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS
(20–79 YEARS), 2017 VS. 2045 (MILLION) 29
TABLE 2 OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 33
TABLE 3 OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY REGION,
2016–2024 (USD MILLION) 33
TABLE 4 NORTH AMERICA: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS,
BY COUNTRY, 2016–2024 (USD MILLION) 34
TABLE 5 EUROPE: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY,
2016–2024 (USD MILLION) 34
TABLE 6 OTC TESTS MARKET FOR IMMUNOASSAYS, BY REGION,
2016–2024 (USD MILLION) 35
TABLE 7 NORTH AMERICA: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY,
2016–2024 (USD MILLION) 35
TABLE 8 EUROPE: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY,
2016–2024 (USD MILLION) 35
TABLE 9 OTC TESTS MARKET FOR DIPSTICKS, BY REGION, 2016–2024 (USD MILLION) 36
TABLE 10 NORTH AMERICA: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY,
2016–2024 (USD MILLION) 36
TABLE 11 EUROPE: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY,
2016–2024 (USD MILLION) 37
TABLE 12 OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 39
TABLE 13 OTC GLUCOSE MONITORING TESTS MARKET, BY REGION,
2016–2024 (USD MILLION) 40
TABLE 14 NORTH AMERICA: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 40
TABLE 15 EUROPE: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 40
TABLE 16 OTC PREGNANCY & FERTILITY TESTS MARKET, BY REGION,
2016–2024 (USD MILLION) 41
TABLE 17 NORTH AMERICA: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 41
TABLE 18 EUROPE: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 42
TABLE 19 OTC INFECTIOUS DISEASE TESTS MARKET, BY REGION,
2016–2024 (USD MILLION) 42
TABLE 20 NORTH AMERICA: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 43
TABLE 21 EUROPE: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 43
TABLE 22 OTC COAGULATION MONITORING TESTS MARKET, BY REGION,
2016–2024 (USD MILLION) 44
TABLE 23 NORTH AMERICA: OTC COAGULATION MONITORING TESTS MARKET,
BY COUNTRY, 2016–2024 (USD MILLION) 44
TABLE 24 EUROPE: OTC COAGULATION MONITORING TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 45
TABLE 25 OTC URINALYSIS TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 45
TABLE 26 NORTH AMERICA: OTC URINALYSIS TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 46
TABLE 27 EUROPE: OTC URINALYSIS TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 46
TABLE 28 OTC CHOLESTEROL TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 47
TABLE 29 NORTH AMERICA: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 47
TABLE 30 EUROPE: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 47
TABLE 31 OTC DRUGS-OF-ABUSE TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 48
TABLE 32 NORTH AMERICA: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 48
TABLE 33 EUROPE: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 49
TABLE 34 OTC OTHER TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 49
TABLE 35 NORTH AMERICA: OTC OTHER TESTS MARKET, BY COUNTRY,
2016–2024 (USD MILLION) 50
TABLE 36 EUROPE: OTC OTHER TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 50
TABLE 37 OTC TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 52
TABLE 38 NORTH AMERICA: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 54
TABLE 39 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 54
TABLE 40 NORTH AMERICA: OTC TESTS MARKET, BY TECHNOLOGY,
2016–2024 (USD MILLION) 54
TABLE 41 US: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 56
TABLE 42 US: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 56
TABLE 43 CANADA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 57
TABLE 44 CANADA: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 58
TABLE 45 EUROPE: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 58
TABLE 46 EUROPE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 59
TABLE 47 EUROPE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 59
TABLE 48 GERMANY: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 60
TABLE 49 GERMANY: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 60
TABLE 50 FRANCE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 61
TABLE 51 FRANCE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 62
TABLE 52 UK: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 62
TABLE 53 UK: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 63
TABLE 54 ROE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 63
TABLE 55 ROE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 64
TABLE 56 APAC: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 66
TABLE 57 APAC: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 66
TABLE 58 ROW: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 67
TABLE 59 ROW: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 68
TABLE 60 PRODUCT LAUNCHES, 2016–2019 72
TABLE 61 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2019 72
TABLE 62 ACQUISITIONS, 2016-2019 73


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 15
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 19
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 DATA TRIANGULATION 20
FIGURE 6 OTC TESTS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION) 22
FIGURE 7 OTC TESTS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION) 23
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OTC TESTS MARKET 24
FIGURE 9 RISING PREVALENCE OF TARGET DISEASES AND DISORDERS IS A KEY DRIVER FOR THE OTC TESTS MARKET 25
FIGURE 10 LATERAL FLOW ASSAYS TO CONTINUE TO DOMINATE THE OTC TESTS
MARKET IN 2024 26
FIGURE 11 GLUCOSE MONITORING TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN OTC TESTS MARKET IN 2018 27
FIGURE 12 OTC TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 28
FIGURE 13 NORTH AMERICA: OTC TESTS MARKET SNAPSHOT 53
FIGURE 14 APAC: OTC TESTS MARKET SNAPSHOT 65
FIGURE 15 OTC TESTS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017 70
FIGURE 16 RANK OF COMPANIES IN THE GLOBAL OTC TESTS MARKET, 2017 71
FIGURE 17 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2018) 74
FIGURE 18 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018) 76
FIGURE 19 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2017) 78
FIGURE 20 LABSTYLE INNOVATIONS: COMPANY SNAPSHOT (2017) 82


★調査レポート[OTC検査の世界市場予測(~2024年)] ( Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024 / MD-7014) 販売に関する免責事項
[OTC検査の世界市場予測(~2024年)] ( Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024 / MD-7014) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆